Ocular Therapeutix, Inc.
Status: Publicly traded
Direct answer
Ocular Therapeutix, Inc. is publicly traded on NASDAQ under the ticker OCUL.
Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage from corneal...
Can you invest in Ocular Therapeutix, Inc.?
Yes. Ocular Therapeutix, Inc. is publicly traded on NASDAQ under the ticker OCUL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ocular Therapeutix, Inc.
Detailed equity research is provided by MarketSnap.